跳至主要内容
临床试验/CTRI/2019/10/021513
CTRI/2019/10/021513已完成4 期

Comparison of the efficacy of oxybutynin with that of mirabegron as an add-on therapy to tamsulosin in patients with persistent storage symptoms presumed to be due to benign prostatic hyperplasia : A randomized controlled trial

JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION RESEARCH0 个研究点目标入组 96 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
96

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Male patients aged 50 years or older with LUTS presumed to be due BPH having urinary urgency at least once per week and a total OAB symptom score (OABSS) ââ?°Â¥ 3 points after ââ?°Â¥ 8 weeks treatment with tamsulosin 0.4mg od

排除标准

  • 1.PVR > 100 ml
  • 2.Q max < 5 ml/s
  • 3.Prior diagnosis of neurogenic bladder
  • 4.Performance of clean intermittent catheterization,
  • 5.Severe bladder diverticulum or urethral stricture,
  • 6.Planning to have a child,
  • 7.Suspected prostate or bladder malignancy
  • 8.Previous urethral surgery or prior diagnosis of urethral stricture disease.
  • 9.Previous intra pelvic irradiation,
  • 10.Suspected recurrent urinary infection,
  • 11.Presence of renal or hepatic impairment,
  • 12.Taking medicines contraindicated or requiring dose adjustments in combination with mirabegron or oxybutynin
  • 13.Patients who have taken mirabegron or any anticholinergic medication in the previous 4 weeks.
  • 14.Judged to be unsuitable for the trial by doctors

研究者

发起方
JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION RESEARCH

相似试验